Mixed Bag Phase 3 Data for ADHD Treatment Presented at ASHP Meeting

CONFERENCE REPORTER: Researchers shared mixed good news for the novel treatment centanafadine for treating attention-deficit/hyperactivity disorder at the American Society of Health-System Pharmacists 2023 Summer Meetings and Exhibition.1 Specifically, they found centanafadine had a better safety profile and demonstrated more favorable tolerability but was less effective than lisdexamfetamine dimesylate (Vyvanse) for adults with ADHD.

Read More

Investigating the Long-Term Safety of ADHD Medication for Children and Adolescents

[Excerpt] Now, a recent study from the Attention Deficit Hyperactivity Drugs Use Chronic Effects (ADDUCE) project, published in The Lancet, aimed to address these concerns by investigating the safety of methylphenidate in children and adolescents over a 2-year period. Technology Networks spoke with Dr. Sarah Inglis, trial manager for the ADDUCE study, to learn more about its findings…

Read More

ADHD in Children: Focus on the Positives

Jami Demuth is the mother of three children in their teens, all of whom have attention deficit hyperactivity disorder (ADHD). Her parenting strategy? She encourages them to find ways to use their ADHD symptoms to their advantage.

Read More

A guide to holiday packing if you have ADHD

Packing for travel when you have ADHD is often achieved by three less-than-ideal methods. The first involves throwing everything in a suitcase a few hours before departure and praying to the travel gods that you have packed at least a few useful items (10 bikinis and zero thermals for a ski trip, anyone?).

Read More